Skip to Main Content

Paper Details

Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis.
6
2023
Venetoclax, advanced MDS, relapsed/refractory AML
Author NameAffiliation
Charlotte M NiemeyerMedical Center, University of Freiburg
  • 1 - 1

Datasets

Release 1.2